Thomas Jefferson UniversitySidney Kimmel Medical College

Main menu:

Cognitive Trials

Active Studies

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non-Carriers.

Low vision depression prevention trial for age related macular degeneration

Improving Function in Age-Related Macular Degeneration